4.3 Article

Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study*

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

Cheng Han Ng et al.

Summary: This study found that diabetic patients with NAFLD have a significantly increased risk of cardiovascular disease, stroke, chronic kidney disease, all-cause mortality, and cardiovascular disease mortality compared to non-diabetic NAFLD individuals. However, prediabetic NAFLD only significantly increases the risk of cardiovascular disease and does not result in a higher risk of mortality.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Article Endocrinology & Metabolism

Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study

Ronald B. Goldberg et al.

Summary: Fatty liver is common in the early stages of diabetes development, and its association with insulin resistance, waist circumference, and triglyceride levels underscores the importance of these markers for hepatic steatosis in this population.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Multidisciplinary Sciences

Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets

Stefan Kabisch et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is commonly associated with Metabolic Syndrome and type 2 diabetes (T2DM), driven by energy imbalance, saturated fats, and simple carbohydrates. Liver fat indices may be useful in predicting NAFLD and allocating further diagnostics to high-risk patients, but more research is needed to develop treatment-sensitive indices.

SCIENTIFIC REPORTS (2021)

Review Endocrinology & Metabolism

Preparing for the NASH Epidemic: A Call to Action

Fasiha Kanwal et al.

Summary: NAFLD and NASH are common conditions with a rising burden, but there are significant gaps between clinical guidelines and practice in managing these diseases. An international conference of experts from various countries was convened to discuss global burden, screening, risk stratification, diagnosis, and management, leading to the development of a comprehensive unified strategy for care.

DIABETES CARE (2021)

Article Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

Summary: NAFLD is a common disease that affects a significant proportion of US adults. Management typically occurs in primary care or endocrine clinics, where accurate staging for fibrosis risk through screening is crucial, requiring consistent, timely, evidence-based, and easily testable management processes.

GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

Alessandro Mantovani et al.

Summary: Studies have shown a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of cardiovascular disease (CVD) incidence. The risk of fatal or non-fatal CVD events is moderately increased with NAFLD, and this risk escalates with the severity of NAFLD, particularly with higher fibrosis stages. These findings suggest that NAFLD may be an independent risk factor for CVD morbidity and mortality.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Advances in non-invasive assessment of hepatic fibrosis

Rohit Loomba et al.

Article Endocrinology & Metabolism

Obesity Represses CYP2R1, the Vitamin D 25-Hydroxylase, in the Liver and Extrahepatic Tissues

Mahmoud-Sobhy Elkhwanky et al.

JBMR PLUS (2020)

Article Gastroenterology & Hepatology

Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)

Kristina Onnerhag et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Medicine, General & Internal

Vitamin D Supplementation and Prevention of Type 2 Diabetes

Anastassios G. Pittas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Nutrition & Dietetics

Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study

Shiying Liu et al.

JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2019)

Review Medicine, Research & Experimental

Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies

Wanvisa Udomsinprasert et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Nutrition & Dietetics

Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation

Jaividhya Dasarathy et al.

JOURNAL OF NUTRITION (2017)

Review Gastroenterology & Hepatology

Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis

Veeravich Jaruvongvanich et al.

DIGESTIVE AND LIVER DISEASE (2017)

Article Gastroenterology & Hepatology

Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis

Mariana Costa Silva et al.

ANNALS OF HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

L. Fedchuk et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Endocrinology & Metabolism

Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial

Anastassios G. Pittas et al.

DIABETES CARE (2014)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment

Nathalie C. Leite et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

Vitamin D and Nonalcoholic Fatty Liver Disease (NAFLD): Is It More Than Just an Association?

Ryan M. Kwok et al.

HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up

Shira Zelber-Sagi et al.

LIVER INTERNATIONAL (2013)

Article Gastroenterology & Hepatology

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

Jeong-Hoon Lee et al.

DIGESTIVE AND LIVER DISEASE (2010)

Article Gastroenterology & Hepatology

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Amy G. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

Anna Kotronen et al.

GASTROENTEROLOGY (2009)